nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA1D—Signaling by GPCR—IL6—breast cancer	6.07e-05	6.07e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOS3—breast cancer	6.07e-05	6.07e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VEGFA—breast cancer	6.06e-05	6.06e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—BRAF—breast cancer	6.01e-05	6.01e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—STAT3—breast cancer	6e-05	6e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MTOR—breast cancer	6e-05	6e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CB—breast cancer	6e-05	6e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOS3—breast cancer	5.97e-05	5.97e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCND1—breast cancer	5.94e-05	5.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APC—breast cancer	5.94e-05	5.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CG—breast cancer	5.94e-05	5.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KIT—breast cancer	5.94e-05	5.94e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—JUN—breast cancer	5.93e-05	5.93e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VEGFA—breast cancer	5.93e-05	5.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—NOS3—breast cancer	5.89e-05	5.89e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CTNNB1—breast cancer	5.89e-05	5.89e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—STAT3—breast cancer	5.87e-05	5.87e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGF—breast cancer	5.87e-05	5.87e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF1—breast cancer	5.85e-05	5.85e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT2—breast cancer	5.85e-05	5.85e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EGFR—breast cancer	5.82e-05	5.82e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTEN—breast cancer	5.79e-05	5.79e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PIK3CA—breast cancer	5.78e-05	5.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP9—breast cancer	5.77e-05	5.77e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL8—breast cancer	5.76e-05	5.76e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MDM2—breast cancer	5.76e-05	5.76e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CDKN1A—breast cancer	5.75e-05	5.75e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PTEN—breast cancer	5.74e-05	5.74e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RAF1—breast cancer	5.74e-05	5.74e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MAPK3—breast cancer	5.73e-05	5.73e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HRAS—breast cancer	5.72e-05	5.72e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RELA—breast cancer	5.71e-05	5.71e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	5.69e-05	5.69e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	5.69e-05	5.69e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ERBB2—breast cancer	5.67e-05	5.67e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MDM2—breast cancer	5.66e-05	5.66e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RAF1—breast cancer	5.65e-05	5.65e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CDKN1B—breast cancer	5.63e-05	5.63e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RELA—breast cancer	5.62e-05	5.62e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	5.62e-05	5.62e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK8—breast cancer	5.61e-05	5.61e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MAPK3—breast cancer	5.61e-05	5.61e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MTOR—breast cancer	5.6e-05	5.6e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CB—breast cancer	5.6e-05	5.6e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AKT1—breast cancer	5.6e-05	5.6e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ERBB2—breast cancer	5.58e-05	5.58e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—BRAF—breast cancer	5.58e-05	5.58e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MYC—breast cancer	5.57e-05	5.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AKT1—breast cancer	5.57e-05	5.57e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	5.56e-05	5.56e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TGFB1—breast cancer	5.56e-05	5.56e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	5.56e-05	5.56e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CASP3—breast cancer	5.51e-05	5.51e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	5.51e-05	5.51e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MTOR—breast cancer	5.51e-05	5.51e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL2—breast cancer	5.51e-05	5.51e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—KRAS—breast cancer	5.5e-05	5.5e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL6—breast cancer	5.48e-05	5.48e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MYC—breast cancer	5.46e-05	5.46e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGFR—breast cancer	5.45e-05	5.45e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TGFB1—breast cancer	5.44e-05	5.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CB—breast cancer	5.44e-05	5.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF1—breast cancer	5.44e-05	5.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT2—breast cancer	5.43e-05	5.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EGFR—breast cancer	5.41e-05	5.41e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—breast cancer	5.39e-05	5.39e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL8—breast cancer	5.38e-05	5.38e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCND1—breast cancer	5.37e-05	5.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—JUN—breast cancer	5.36e-05	5.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HRAS—breast cancer	5.35e-05	5.35e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGFR—breast cancer	5.34e-05	5.34e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SRC—breast cancer	5.32e-05	5.32e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CTNNB1—breast cancer	5.32e-05	5.32e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOS3—breast cancer	5.3e-05	5.3e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL8—breast cancer	5.3e-05	5.3e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HRAS—breast cancer	5.26e-05	5.26e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CDKN1B—breast cancer	5.26e-05	5.26e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	5.22e-05	5.22e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP9—breast cancer	5.21e-05	5.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AKT1—breast cancer	5.2e-05	5.2e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	5.19e-05	5.19e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VEGFA—breast cancer	5.18e-05	5.18e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PTEN—breast cancer	5.18e-05	5.18e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	5.17e-05	5.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	5.17e-05	5.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	5.16e-05	5.16e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CASP3—breast cancer	5.15e-05	5.15e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—KRAS—breast cancer	5.15e-05	5.15e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL2—breast cancer	5.14e-05	5.14e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—STAT3—breast cancer	5.13e-05	5.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL6—breast cancer	5.12e-05	5.12e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	5.12e-05	5.12e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—KRAS—breast cancer	5.11e-05	5.11e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CASP3—breast cancer	5.07e-05	5.07e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK8—breast cancer	5.07e-05	5.07e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL2—breast cancer	5.06e-05	5.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AKT1—breast cancer	5.05e-05	5.05e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	5.05e-05	5.05e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—KRAS—breast cancer	5.04e-05	5.04e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL6—breast cancer	5.04e-05	5.04e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MDM2—breast cancer	5.03e-05	5.03e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RAF1—breast cancer	5.01e-05	5.01e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCND1—breast cancer	5.01e-05	5.01e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—JUN—breast cancer	5e-05	5e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RELA—breast cancer	4.99e-05	4.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CTNNB1—breast cancer	4.96e-05	4.96e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ERBB2—breast cancer	4.96e-05	4.96e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCND1—breast cancer	4.93e-05	4.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOS3—breast cancer	4.93e-05	4.93e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—JUN—breast cancer	4.92e-05	4.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK3—breast cancer	4.9e-05	4.9e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MTOR—breast cancer	4.9e-05	4.9e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	4.9e-05	4.9e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	4.89e-05	4.89e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP9—breast cancer	4.87e-05	4.87e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CDKN1A—breast cancer	4.85e-05	4.85e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTEN—breast cancer	4.84e-05	4.84e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SRC—breast cancer	4.8e-05	4.8e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP9—breast cancer	4.79e-05	4.79e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	4.77e-05	4.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MYC—breast cancer	4.77e-05	4.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTEN—breast cancer	4.76e-05	4.76e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TGFB1—breast cancer	4.76e-05	4.76e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK8—breast cancer	4.73e-05	4.73e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PIK3CA—breast cancer	4.73e-05	4.73e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AKT1—breast cancer	4.72e-05	4.72e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL8—breast cancer	4.7e-05	4.7e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTEN—breast cancer	4.7e-05	4.7e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	4.69e-05	4.69e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VEGFA—breast cancer	4.68e-05	4.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MDM2—breast cancer	4.68e-05	4.68e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HRAS—breast cancer	4.67e-05	4.67e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGFR—breast cancer	4.66e-05	4.66e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK8—breast cancer	4.66e-05	4.66e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RAF1—breast cancer	4.66e-05	4.66e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AKT1—breast cancer	4.65e-05	4.65e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RELA—breast cancer	4.64e-05	4.64e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—STAT3—breast cancer	4.63e-05	4.63e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PIK3CA—breast cancer	4.63e-05	4.63e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ERBB2—breast cancer	4.61e-05	4.61e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	4.59e-05	4.59e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—breast cancer	4.58e-05	4.58e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MTOR—breast cancer	4.55e-05	4.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	4.55e-05	4.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	4.54e-05	4.54e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CASP3—breast cancer	4.5e-05	4.5e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL2—breast cancer	4.5e-05	4.5e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SRC—breast cancer	4.49e-05	4.49e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—breast cancer	4.48e-05	4.48e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL6—breast cancer	4.47e-05	4.47e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK3—breast cancer	4.43e-05	4.43e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SRC—breast cancer	4.42e-05	4.42e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—KRAS—breast cancer	4.41e-05	4.41e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCND1—breast cancer	4.38e-05	4.38e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HRAS—breast cancer	4.38e-05	4.38e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—JUN—breast cancer	4.37e-05	4.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL8—breast cancer	4.37e-05	4.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VEGFA—breast cancer	4.37e-05	4.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HRAS—breast cancer	4.34e-05	4.34e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	4.34e-05	4.34e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—STAT3—breast cancer	4.33e-05	4.33e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MYC—breast cancer	4.31e-05	4.31e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VEGFA—breast cancer	4.3e-05	4.3e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TGFB1—breast cancer	4.29e-05	4.29e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HRAS—breast cancer	4.28e-05	4.28e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	4.27e-05	4.27e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—STAT3—breast cancer	4.26e-05	4.26e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP9—breast cancer	4.26e-05	4.26e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	4.24e-05	4.24e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTEN—breast cancer	4.23e-05	4.23e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	4.22e-05	4.22e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGFR—breast cancer	4.21e-05	4.21e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL6—breast cancer	4.19e-05	4.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CASP3—breast cancer	4.18e-05	4.18e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL2—breast cancer	4.18e-05	4.18e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL6—breast cancer	4.16e-05	4.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK8—breast cancer	4.14e-05	4.14e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK3—breast cancer	4.13e-05	4.13e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AKT1—breast cancer	4.13e-05	4.13e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL6—breast cancer	4.1e-05	4.1e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CA—breast cancer	4.08e-05	4.08e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCND1—breast cancer	4.07e-05	4.07e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK3—breast cancer	4.07e-05	4.07e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—JUN—breast cancer	4.06e-05	4.06e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	4.05e-05	4.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	4.03e-05	4.03e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MYC—breast cancer	4.02e-05	4.02e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TGFB1—breast cancer	4.01e-05	4.01e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—KRAS—breast cancer	3.98e-05	3.98e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MYC—breast cancer	3.96e-05	3.96e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP9—breast cancer	3.95e-05	3.95e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TGFB1—breast cancer	3.95e-05	3.95e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	3.94e-05	3.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGFR—breast cancer	3.93e-05	3.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTEN—breast cancer	3.93e-05	3.93e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SRC—breast cancer	3.92e-05	3.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—breast cancer	3.92e-05	3.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGFR—breast cancer	3.87e-05	3.87e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AKT1—breast cancer	3.86e-05	3.86e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK8—breast cancer	3.85e-05	3.85e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AKT1—breast cancer	3.83e-05	3.83e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VEGFA—breast cancer	3.82e-05	3.82e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AKT1—breast cancer	3.78e-05	3.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—STAT3—breast cancer	3.78e-05	3.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HRAS—breast cancer	3.75e-05	3.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—KRAS—breast cancer	3.72e-05	3.72e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—KRAS—breast cancer	3.66e-05	3.66e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	3.65e-05	3.65e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SRC—breast cancer	3.65e-05	3.65e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK3—breast cancer	3.61e-05	3.61e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL6—breast cancer	3.58e-05	3.58e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VEGFA—breast cancer	3.55e-05	3.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—breast cancer	3.54e-05	3.54e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MYC—breast cancer	3.52e-05	3.52e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—STAT3—breast cancer	3.52e-05	3.52e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TGFB1—breast cancer	3.51e-05	3.51e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGFR—breast cancer	3.44e-05	3.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	3.41e-05	3.41e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HRAS—breast cancer	3.38e-05	3.38e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	3.36e-05	3.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK3—breast cancer	3.36e-05	3.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AKT1—breast cancer	3.34e-05	3.34e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CA—breast cancer	3.32e-05	3.32e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AKT1—breast cancer	3.31e-05	3.31e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—breast cancer	3.3e-05	3.3e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MYC—breast cancer	3.27e-05	3.27e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TGFB1—breast cancer	3.26e-05	3.26e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—breast cancer	3.25e-05	3.25e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—KRAS—breast cancer	3.25e-05	3.25e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL6—breast cancer	3.24e-05	3.24e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGFR—breast cancer	3.19e-05	3.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HRAS—breast cancer	3.16e-05	3.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HRAS—breast cancer	3.11e-05	3.11e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL6—breast cancer	3.02e-05	3.02e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KRAS—breast cancer	3.02e-05	3.02e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKT1—breast cancer	2.99e-05	2.99e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	2.98e-05	2.98e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL6—breast cancer	2.98e-05	2.98e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—breast cancer	2.89e-05	2.89e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKT1—breast cancer	2.79e-05	2.79e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	2.77e-05	2.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HRAS—breast cancer	2.76e-05	2.76e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKT1—breast cancer	2.74e-05	2.74e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AKT1—breast cancer	2.71e-05	2.71e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—breast cancer	2.68e-05	2.68e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6—breast cancer	2.64e-05	2.64e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HRAS—breast cancer	2.57e-05	2.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6—breast cancer	2.46e-05	2.46e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT1—breast cancer	2.44e-05	2.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT1—breast cancer	2.27e-05	2.27e-05	CbGpPWpGaD
